Combine and conquer: advantages and disadvantages of fixed-dose combination therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combine and conquer: advantages and disadvantages of fixed-dose combination therapy

Published:2012-10-25 Issue:4 Volume:15 Page:291-300
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bell D. S. H.¹

Affiliation:

1. Southside Endocrinology; University of Alabama Medical School; Birmingham; AL; USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12015/fullpdf

Reference77 articles.

1. Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes;Vouri;J Manag Care Pharm,2011

2. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004;Dodd;Curr Med Res Opin,2009

3. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999

4. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes;Garber;J Clin Endocrinol Metab,2003

5. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea;Goldstein;Clin Ther,2003

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib;Biochemistry and Biophysics Reports;2024-09

2. Racial Comparison of the Pharmacokinetics and Safety of Fixed-dose Combination of Dapagliflozin/Sitagliptin in Western and Korean Healthy Adults;Clinical Therapeutics;2024-09

3. Relationship between Prices of Fixed-dose and Free-equivalent Combination: A Survey of Medicines in China's National Reimbursement Drug List;2024-08-29

4. Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects;Drug Design, Development and Therapy;2024-07

5. Apixaban and clopidogrel in a fixed-dose combination: Formulation and in vitro evaluation;Saudi Pharmaceutical Journal;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3